Caraco to add 600 jobs by 2012

Even in this era of big pharma layoffs, a few companies are still adding jobs. Take generics maker Caraco Pharmaceutical Laboratories, majority-owned by of India's Sun Pharmaceuticals. The company is moving forward with its previously announced plans to expand its Detroit-area manufacturing plant. The $22 million growth plan includes 600 new jobs by 2012.

Leveraging its connections with Sun, Caraco managed to boost sales by 200 percent last fiscal year, to $$350 million. Profits were $35.4 million. Sun gives Caraco access to capital, R&D and inexpensive raw materials for the 54 generics it makes in Michigan. And Caraco markets and distributes Sun's products in the U.S.

- read the story at the Detroit News

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.